Incidence of Intraoperative Vasoplegic Syndrome in Lung Transplantation.
bilateral lung transplantation
cardiopulmonary bypass
cardiothoracic anesthesia
cardiothoracic surgery
cystic fibrosis
lung transplantation
vasoplegia
vasoplegic syndrome
Journal
Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
received:
15
05
2023
revised:
16
08
2023
accepted:
17
08
2023
medline:
6
11
2023
pubmed:
30
9
2023
entrez:
29
9
2023
Statut:
ppublish
Résumé
Severe hypotension and low systemic vascular resistance in the setting of adequate cardiac output, known as "vasoplegic syndrome" (VS), is a physiologic disturbance reported in 9% to 44% of cardiac surgery patients. Although this phenomenon is well-documented in cardiac surgery, there are few studies on its occurrence in lung transplantation. The goal of this study was to characterize the incidence of VS in lung transplantation, as well as identify associated risk factors and outcomes. Retrospective study of single and bilateral lung transplants from April 2013 to September 2021. The study was conducted at an academic hospital. Patients ≥18 years of age who underwent lung transplantation. None. The authors defined VS as mean arterial pressure <65 mmHg, cardiac index ≥2.2 L/min/m The incidence of VS in lung transplantation is comparable to that of cardiac surgery. Interestingly, male sex and cystic fibrosis are strong risk factors. Identifying lung transplant recipients at increased risk of VS may be crucial to anticipating intraoperative complications.
Identifiants
pubmed: 37775341
pii: S1053-0770(23)00711-5
doi: 10.1053/j.jvca.2023.08.136
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2531-2537Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest E. Methangkool receives consulting fees from Edwards LifeSciences and author royalties from UpToDate, Inc.